- Filed
- Nov 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 11, 2025 | 92.21M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 92.21M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 92.21M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 92.21M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 59.9M sh |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$15K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$1.36M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $15K |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $84K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$37.53M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$37.92M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$33.16M |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$43.68M |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$47.99M |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$43.8M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $38.8M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $34.45M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $38.94M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $35.3M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.04M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.74M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $1.41M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $2.14M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.00 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.05 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.00 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.05 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $418K |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $1.42M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $500K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $2.72M |
| Net Income | Q3 2025 · Sep 30, 2025 | $116K |
| Net Income | Q3 2025 · Sep 30, 2025 | −$1.84M |
| Net Income | Q3 2025 · Sep 30, 2024 | $4.97M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$1.1M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$220K |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$959K |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$356K |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$2.55M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $412K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $1.11M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $307K |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $809K |
| Revenue | Q3 2025 · Sep 30, 2025 | $610K |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.56M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $451K |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $977K |